|Publication number||USRE37315 E1|
|Application number||US 08/889,825|
|Publication date||Aug 7, 2001|
|Filing date||Jul 8, 1997|
|Priority date||Nov 11, 1991|
|Also published as||CA2123137A1, CA2123137C, DE69218619D1, DE69218619T2, EP0612228A1, EP0612228B1, US5431648, US20020077625, USRE40559, WO1993009724A1|
|Publication number||08889825, 889825, US RE37315 E1, US RE37315E1, US-E1-RE37315, USRE37315 E1, USRE37315E1|
|Original Assignee||Medical Enterprises Ltd.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (44), Non-Patent Citations (4), Referenced by (14), Classifications (16), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention concerns a radiating device for hyperthermia and, more particularly, a radiofrequency radiating device, for hyperthermal treatment of tumors of the bladder.
Devices for hyperthermal treatment of various human body illnesses are already known, and they use heating liquids, light radiations, radiofrequency antennas, thermistors, and so on.
U.S. Pat. No. 4,776,334 describes a catheter for treating tumors by inserting within the tumor to be treated a radiofrequency device provided with temperature sensors.
French patent application 2600205 concerns an apparatus for light irradiation of a cavity with the help of an inflatable balloon and of light sensors.
In U.S. Pat. No. 4,154,246 there is described a radiofrequency resonating circuit which is introduced in natural cavities of the body or directly inserted into the tumoral mass.
German patent application No. 2,848,636 claims usage of a heated liquid which is circulated in a closed loop by means of a pump within a body cavity, wherein the liquid temperature is controlled by an external thermostat. EP-A-0 370 890 discloses a radiating urethral device for hyperthermia including a catheter provided with an inflatable balloon and adapted to receive one or more liquid flows passing therethrough, a radiofrequency radiating antenna, and one or more thermocouples, the radiating antenna being submerged within one said liquid flow coming back from the closed terminal end of the antenna. The radiating device comprises in addition a separate rectal control means.
GB-A-2 045 620 relates to an applicator for hyperthermia comprising a rectal radiating probe and a spaced apart transurethral catheter including a temperature sensing means and an inflatable balloon. U.S. Pat. No. 4,957,765 discloses a transurethral radiating applicator for hyperthermia including a multi-tubes balloon type catheter comprising closed end tubes respectively surrounding a helical coil antenna and a temperature sensor, as well as a passive drainage tube for urine.
It is an object of this invention to provide a device for hyperthermal treatment of tumors within natural cavities of the human body, which gathers the advantages of the known devices while being free from their drawbacks.
The device according to this invention substantially comprises a flexible triple path catheter carrying a radiofrequency radiating antenna, sealingly sheathed together with the shielded cable providing power supply and with several thermocouples within a plastic casing and surrounded by a flow of liquid; a second path carries the power supply cables for several outer thermocouples, which are flooded by return flow of said liquid, and a third path allowing a fluid to flow through in order to inflate a balloon located near the catheter distal end, once the latter has been introduced into the cavity to be treated.
This invention will be described more particularly in the following based on a specific embodiment thereof reported herein for exemplary and non limiting purposes, as well as on the attached schematic drawings. In connection with the above it should be pointed out that in said drawings the parts shown are not to scale and the mutual dimensions are out of proportion, the members having in fact a very thin cross-section.
FIG. 1 shows schematically, in an enlarged scale, the distal end of the device according to this invention, which has to be introduced into a natural cavity of the human body;
FIG. 1A shows an enlarged schematic cross-section of the device according to this invention, taken along line A—A of FIG. 1;
FIG. 2 is a schematic of some structural details of a radiofrequency antenna shown in general within the device of FIG. 1;
FIG. 2A shows a schematic enlarged cross-section of the radiating antenna, taken along line A—A of FIG. 2;
FIG. 3 is a schematic of the proximal end of the device according to this invention, opposite to the distal end shown in FIG. 1;
FIG. 4 is a plot of the intensity of the radiation generated by the radiating antenna of FIG. 2, along the longitudinal axis thereof;
FIG. 5 shows schematically the distal end of the device of FIG. 1, as it is seen after having been introduced into a urinary bladder; and
FIG. 6 shows schematically the structure at the distal end of the device shown in FIG. 1, when ready for introduction into the organ to be treated.
The device according to this invention has a shape and consistency of a flexible catheter whose distal end, as it is shown in FIG. 1, encloses therewithin an antenna 1 surrounded by a flow of liquid 2 which is introduced into the bladder through an opening 3 and, after being freely circulated within said bladder, is again sucked into the catheter through an opening 4. Said opening 4 is in communication with a second way or catheter side channel 5 housing the leads of several thermocouples, like for instance 6, 6′, 6″ adapted to be deflected outwards by inflating a balloon 7 in which a gaseous fluid or a liquid is made to flow through a third path or side channel 8 and through an end opening 9.
The catheter opposite (proximal) end (FIG. 3) whose tip is shown in FIG. 1, has three diverging inlets corresponding to the three paths or channels 2, 5, 8 of said catheter. Within center inlet 10 there is inserted with a pressure fit a plug 11 provided with a center through passage and with a side branch 13; in center passage 12 of plug 11 there is in turn pressure fitted a second plug 14 which is provided as well with a center opening 15. Shielded cable 16 supplying power to antenna 1 runs through the center passages 12 and 15 of said two coaxially arranged plugs, while side branch 13 is provided as an inlet and an outlet of a conditioning fluid flowing along channel 2. Thermocouple power supply cables 6, 6′, 6″ are laid through side entrance 17 provided with a branch 18, and they run along side path or channel 5 having said conditioning liquid flowing in a reverse direction therethrough, said liquid entering and exiting in turn through said branch 18. The other side entrance 19 is provided with a one-way valve 20 for introducing the fluid that, flowing along second side channel 8, is used to inflate balloon 7.
Slightly downstream from said three entrances 10, 17, 19 there is provided, in a sleeve-like fashion and in intimate contact around the catheter body, a heat exchanger 31, operated in a known fashion from outside, and used to cool or to heat said conditioning liquid flowing through central channel 2 and coming back through side channel 5, or viceversa.
Referring now to FIGS. 2 and 2A, radiating antenna 1 will be described more in detail; the useful radiating portion of linear dipole antenna 1 comprises a terminal coil-shaped segment 21 of central conductor 22 which, immediately upstream from coil 21 is tightly surrounded, in sequence, by a first plastic inner sleeve 23, by a metal braiding 24, by a second intermediate plastic sleeve 25, by a metal cylinder 26 electrically connected with shield 24, and eventually by an outer plastic sleeve 27.
Immediately beneath sleeve 27 there is provided the power supply cables for several thermocouples located in a way suitable to detect the operating temperatures in predetermined positions of the antenna and of the power supply cable thereof. For instance, a first thermocouple 28 may be located in the position of the stretch of catheter which will be located at the prostatic urethra when the catheter with its antenna are inserted within the bladder; a second thermocouple 29 slightly upstream from antenna 1, at the bladder neck, while a third thermocouple 30 is located close to central conductor 22, between metal cylinder 26 and end coil 21, after having been wrapped with one or more coils around shield 24 immediately upstream from intermediate sleeve 25 and metal cylinder 26, and a second time, with a larger number of coils, around the stretch of central lead 22 projecting out of metal cylinder 26 before winding up to form end coil 21, the stretch of thermocouple 30 power supply cable connecting said two points being inserted with intimate contact between intermediate sleeve 25 and metal cylinder 26.
In any case, the end stretches of the power supply cables, immediately ahead of the thermocouples, are wrapped in a number of helical coils in order to increase the thermal capacity and the radiofrequency resistance of the ends which are designated to detect the temperature, while reducing to a minimum, or completely avoiding the dispersive thermal conduction along said cables.
In FIG. 1A, which shows schematically a cross-section of the catheter according to this invention, taken in any position of the stretch going from heat exchanger 31 to intermediate sleeve 25, there is shown side channel 5 carrying the power supply cables of thermocouples 6, 6′, 6″ and side channel 8 for the flow of the fluid used to inflate balloon 7, both said channels 5 and 8 being managed within the thickness of the actual catheter whose inner bore 2 intended for the flow of the conditioning liquid carries, in a central position, shielded cable 16 comprised of central conductor 22, inner sleeve 23, shield 24 and outer sleeve 27, as well as inner thermocouples 28, 29 and 30 power supply cables (not shown).
FIG. 2A is a schematic cross-section of antenna 1, taken along line A—A of FIG. 2. The following are shown therein, starting from the center: conductor 22, inner sleeve 23, metal shield 24, an intermediate sleeve 25, a metal cylinder 26, and outer sleeve 27, as well as thermocouple 30 power supply conductor.
FIG. 4 is a diagram showing the radiation intensity starting from the coil-shaped end 21 of antenna 1 towards shielded power supply cable 22, 16. As it is shown, intensity is a maximum when passing from radiating coil 21 to the stretch protected by metal cylinder 26, and it tends to nil at the position of shielded cable 16.
There is shown schematically in FIG. 5 the longitudinal section of the catheter provided with a radiating antenna according to this invention, once it has been introduced into the bladder, in an operative condition. The catheter, carrying the radiating antenna therewithin, is introduced into bladder 32 through the urethra, in such a way that the rear end of protective metal cylinder 26 is located approximately at the bladder neck, in the transition area between prostrate 33 and bladder 32, while simultaneously taking care that the catheter front end does not subject the bladder internal wall to any pressure. Once the catheter has been introduced into the bladder in such a way, one actuates the supply pump of conditioning liquid 2 preferably comprising a solution of a selective citotoxicity cytotoxicity substance, which is accordingly forced to circulate through the bladder coming out from opening 3 and going back through opening 4, or viceversa, along side channel 5 which carries the power supply cables of thermocouples 6, 6′, 6″ therewithin. The liquid forced circulation, provided by the variable flowrate supply pump, suitably combined with an outer balancing and degassing chamber, allows the volume of liquid within the bladder to be balanced at will, in such a way as to compensate the pathological or physiological urine production, while thoroughly ejecting the gases generated or unwillingly introduced in circulation, out of the bladder, in order to prevent irradiation non-uniformities which would otherwise be caused by coexistance of anisotropic media. Once bladder 32 has been completely filled with conditioning liquid 2, ballon 7 is inflated by introducing a fluid, which may be a gas but it is preferably a liquid, along side channel 8 and through the end opening 9 thereof; ballon 7 inflated as mentioned above, pushes then against outer thermocouples 6, 6′, 6″ power supply cables thereby moving said thermocouples into tangential engagement against bladder wall 32 in different positions, in order to detect the temperatures prevailing therein as caused by irradiation generated by antenna 1. The possibility of changing the location and the number of the outer thermocouples, enables the thermocouples to be positioned at will, on the bladder wall, or in any case place of the body organ to be treated, while being able to individually check the temperatures in the various locations. The inflated ballon 7 protects the bladder neck wall from an excess heat caused by the proximity of the radiating antenna, and in the meantime it prevents the catheter from being accidentally displaced or from coming out through the bladder neck.
The dimensions of antenna 1 are such that it may be freely positioned along the catheter while being obviously wholly contained within the human bladder to be treated, but in the meantime they must be suitable to generate a therapeutically active radiation, in order to reach the temperatures considered lethal for the cancer cells. Since the physical length of an antenna is related to the virtual electrical length thereof through an equation involving the impedence of said antenna, as well as the impedence deriving from the environment irradiated by the antenna, the antenna electrical length comes out to be inversely proportional to the irradiated medium conductivity. Accordingly, since the conductivity of an aqueous solution is for instance many times higher than the conductivity of air, when operating in an aqueous environment it is possible to use an antenna which is physically quite shorter than the length needed if it were necessary to operate in air.
The dipole according to this invention corresponds to a dipole of the quarter wave type and in the aqueous environment comprising the solution filled bladder, it makes it possible to operate at frequencies in the range of 900-1000 MHz; in particular, a frequency of 915 MHz has been chosen since very different frequencies would result in penetration, intensity, and other effects not always exactly predictable and controllable in the body tissues, since in general high frequencies have a low penetration power and therefore they do not provide the desired local heating, while lower frequencies, having a higher penetration power, may get deeper tissues involved and damaged.
On the other hand, radiations having different wavelengths might create a disturbance for radio and telephone communications, protected by constraints imposed by the legislations of the various countries.
In order to reduce to a minimum and possibly to nil the influence of the radiofrequency field on the thermocouples, as well as the various thermoelectric effects connatural with said thermocouples, the supply cable end stretches close to the thermocouples are wound into an helical shape whereby the temperature measured in the various sensing points is a reliable data, unaffected by said influences. The above structure construction prevents measuring errors due to conduction, it provides a reliable temperature indication, for instance exactly in the area of the dipole power supply position in the case of thermocouple 30, and it reduces in an extremely effective manner the thermocouple self-heating process due to radiofrequencies, also when there is an extremely high concentration of energy, whereby said structures are almost unaffected by the disturbances in the radio-frequency field.
Since the sizes, and in particular the cross-sections of the plural device components according to this invention must be extremely small, to suit the particular field of use desired for the device, the energy losses due for instance to self-heating of the antenna power supply cable are particularly high, for instance in the range of 20-40%. Since this undesirable self-heating, due to the Joule effect, might cause excessive heating of the urethral walls, and accordingly a discomfort for the patient subjected to treatment, or even damages to the tissues, the antenna cable, and the antenna itself are continuously cooled, while in operation, by using the conditioning liquid flow directed to the bladder and then withdrawn again therefrom, whereby a simultaneous control action is obtained, for controlling the temperature prevailing both in the liquid within the bladder and along the urethra. Temperature control is effected by variations of the conditioning liquid supply flow and of the cooling source temperature. In such a way it is possible both to increase the temperature and to withdraw heat.
In order to enable outer thermocouples 6, 6′, 6″ for detecting the bladder wall temperature to be safely deflected outwards when balloon 7 is inflated, the power supply cables thereof are reinforced along their whole length by inserting within the protecting sheath thereof a thin stainless steel wire providing them with the required rigidity and flexibility. The presence of said reinforcing wire provides as well the thermocouple power supply cables with the mechanical strength necessary to bear the compressive and tensile stresses caused when the cables are inserted within side channel 5, and when thermocouples 6, 6′, 6″ are laid in the desired locations.
When the catheter, provided with all its components, is introduced into the urethral channel, all the way to the bladder, the ends of outer thermocouples 6, 6′, 6″ projecting upstream of balloon 7 through opening 4 are temporarily locked by inserting them, downstream of balloon 7, in one or more notches provided, as the case may be, in suitable positions according to the different body organ or the particular patient to be treated, close to the catheter end, as it is shown in FIG. 6. When balloon 7 is inflated it causes the thermocouple ends to come out from the notches and then to deflect outwards until the thermocouple tips come into engagement with the bladder wall. The particular outwards deflecting system of thermocouples 6, 6′, 6″ causes the ends of the respective power supply cables comprising the actual thermocouple, to tangentially engage the bladder wall, whereby no excessive concentrated pressures are generated. On the other hand, the tangential position taken by the thermocouple tips when contacting the bladder wall, makes it possible to measure the actual temperature of the wall position considered in that at the boundary between said wall and the liquid filling the bladder there is a thin liquid layer substantially stationary, which is not affected by the liquid circulation within the bladder, since it clings to the tissue because of a physical attraction, while the coil shape of the cable terminal stretches increases the thermal capacity of the thermocouple whose diameter, inclusive of the coils, is less than 0,7 mm whereby the thermocouple is completely submerged within the liquid stationary layer having a thickness of approximately 1 mm.
After the thermocouples have been deflected outwards within the bladder, it is still possible to modify their location by performing pushing and/or pulling actions on the reinforced power supply cables, as mentioned above, and possibly by rotating the catheter containing them. Control of the temperature detected on the bladder walls and/or within the circulating liquid mass, is obtained by changing the flowrate of said liquid from few cubic centimeters per minute to several tens of cubic centimeters per minute. The circulated fluid circulating system prevents permanence or formation and build-up of possible gas bubbles within the bladder or through the circuit, in that air or other gas bubbles having possibly formed or being already present, are entrained out by the continuous flow and exhausted to the outer environment in an appropriate position of the outer pumping circuit. In addition, the liquid circulation provided as above prevents the antenna and the environment thereof from overheating, therefore from causing undesirable reactions within the circulating liquid.
It is pointed out herein that all the antenna and thermocouple components contacted by the liquid circulating within the bladder are sealingly lined and insulated from the outer environment by a polytetrafluoroethylene layer whereby, after each usage and application they may be sterilized for subsequent further use.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4154246||Jul 25, 1977||May 15, 1979||Leveen Harry H||Field intensification in radio frequency thermotherapy|
|US4375220||May 9, 1980||Mar 1, 1983||Matvias Fredrick M||Microwave applicator with cooling mechanism for intracavitary treatment of cancer|
|US4662383||Sep 23, 1983||May 5, 1987||Kureha Kagaku Kogyo Kabushiki Kaisha||Endotract antenna device for hyperthermia|
|US4776334||Mar 3, 1987||Oct 11, 1988||Stanford University||Catheter for treatment of tumors|
|US4813429||May 5, 1987||Mar 21, 1989||Biodan Medical Systems Ltd.||Catheter and probe|
|US4924863||May 4, 1988||May 15, 1990||Mmtc, Inc.||Angioplastic method for removing plaque from a vas|
|US4967765||Jul 28, 1988||Nov 6, 1990||Bsd Medical Corporation||Urethral inserted applicator for prostate hyperthermia|
|US4979948||Apr 13, 1989||Dec 25, 1990||Purdue Research Foundation||Method and apparatus for thermally destroying a layer of an organ|
|US5000734||Jan 26, 1989||Mar 19, 1991||Georges Boussignac||Probe intended to be introduced within a living body|
|US5007437||Apr 19, 1990||Apr 16, 1991||Mmtc, Inc.||Catheters for treating prostate disease|
|US5084044 *||Jul 14, 1989||Jan 28, 1992||Ciron Corporation||Apparatus for endometrial ablation and method of using same|
|US5090958||Oct 5, 1990||Feb 25, 1992||Harvinder Sahota||Balloon catheters|
|US5103804||Jul 3, 1990||Apr 14, 1992||Boston Scientific Corporation||Expandable tip hemostatic probes and the like|
|US5114423||May 9, 1990||May 19, 1992||Advanced Cardiovascular Systems, Inc.||Dilatation catheter assembly with heated balloon|
|US5150717 *||Sep 18, 1990||Sep 29, 1992||Arye Rosen||Microwave aided balloon angioplasty with guide filament|
|US5168880||Sep 19, 1990||Dec 8, 1992||Olympus Optical Co., Ltd.||Apparatus for dielectric-heating living body by high-frequency current and apparatus therefor|
|US5191883||May 22, 1990||Mar 9, 1993||Prutech Research And Development Partnership Ii||Device for heating tissue in a patient's body|
|US5195965||Mar 7, 1991||Mar 23, 1993||Shantha Totada R||Method and apparatus for localized treatment of human viral infections and cancers|
|US5220927||Mar 15, 1990||Jun 22, 1993||Bsd Medical Corporation||Urethral inserted applicator for prostate hyperthermia|
|US5249585||Nov 5, 1990||Oct 5, 1993||Bsd Medical Corporation||Urethral inserted applicator for prostate hyperthermia|
|US5257977||Mar 14, 1991||Nov 2, 1993||Argomed Ltd.||Technique for localized thermal treatment of mammals|
|US5292320 *||Jul 6, 1992||Mar 8, 1994||Ceramoptec, Inc.||Radial medical laser delivery device|
|US5292321 *||Mar 1, 1993||Mar 8, 1994||Lee Benjamin I||Thermal balloon angioplasty with thermoplastic stent|
|US5301687||Jun 6, 1991||Apr 12, 1994||Trustees Of Dartmouth College||Microwave applicator for transurethral hyperthermia|
|US5330518 *||Mar 6, 1992||Jul 19, 1994||Urologix, Inc.||Method for treating interstitial tissue associated with microwave thermal therapy|
|US5336222 *||May 14, 1993||Aug 9, 1994||Boston Scientific Corporation||Integrated catheter for diverse in situ tissue therapy|
|US5344435||Nov 5, 1990||Sep 6, 1994||Bsd Medical Corporation||Urethral inserted applicator prostate hyperthermia|
|US5403311 *||Mar 29, 1993||Apr 4, 1995||Boston Scientific Corporation||Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue|
|US5472441||Mar 11, 1994||Dec 5, 1995||Zomed International||Device for treating cancer and non-malignant tumors and methods|
|US5505730 *||Jun 24, 1994||Apr 9, 1996||Stuart D. Edwards||Thin layer ablation apparatus|
|US5599345||Aug 24, 1994||Feb 4, 1997||Zomed International, Inc.||RF treatment apparatus|
|US5599346||Aug 24, 1994||Feb 4, 1997||Zomed International, Inc.||RF treatment system|
|US5697927||Mar 16, 1994||Dec 16, 1997||Cardiac Pathways Corporation||Catheter for RF ablation with cooled electrode and apparatus for use therewith|
|DE2848636A1||Nov 9, 1978||May 22, 1980||Mark||Cavity scavenging device for cancer hyperthermia treatment - has inlet and outlet channels coupled to external scavenging liq. circuit contg. pump, thermostat and heater|
|DE3707921A1||Mar 12, 1987||Sep 17, 1987||Olympus Optical Co||Medical treatment device|
|EP0115420A2||Jan 24, 1984||Aug 8, 1984||Kureha Kagaku Kogyo Kabushiki Kaisha||A device for hyperthermia|
|EP0321614A1||Dec 21, 1987||Jun 28, 1989||Reynaldo Calderon||Systems for retrograde perfusion in the body for curing it of a disease or immune deficiency|
|EP0368161A2||Nov 3, 1989||May 16, 1990||Omron Tateisi Electronics Co.||Electrode structure for high frequency hyperthermia device|
|EP0370890A1||Nov 21, 1989||May 30, 1990||Technomed Medical Systems||Apparatus for the surgical treatment of tissues by hyperthermia, preferably the prostate, equipped with heat protection means preferably comprising means forming radioreflecting screen|
|FR2600205A1||Title not available|
|FR2679456A1||Title not available|
|GB2045620A||Title not available|
|WO1989011311A1||May 18, 1989||Nov 30, 1989||Kasevich Associates, Inc.||Microwave balloon angioplasty|
|WO1990003152A1||Sep 25, 1989||Apr 5, 1990||John Considine||Electro-surgical apparatus for removing tumours from hollow organs of the body|
|1||L. Da Pozzo et al., "Intravesical Microwave-induced Hyperthermia and Mitomycin C for Selected Multifocal Unresectable Superficial Bladder Tumors," Poster presented at the XIIth Congress of The European Association of Urology, Paris, Sep. 1-4, 1996.|
|2||R. Colombo et al., "A New Approach Using Local Combined Microwave Hyperthermia and Chemotherapy in Superficial Transitional Bladder Carcinoma Treatment," J. Urology, vol. 153, pp. 959-963, (Mar. 1995).|
|3||R. Colombo et al., "Neoadjuvant Combined Microwave Induced Local Hyperthermia and Topical Chemotherapy Versus Chemotherapy Alone for Superficial Bladder Cancer," J. Urology, vol. 155, No. 4, pp. 1227-1232, (Apr. 1996).|
|4||Z. Leib et al., "Mitomycin C (MMC) vs. MMC Combined with Local Microwave Hyperthermia (LMWH) as Prophylaxis of Recurrence of Superficial Transitional Bladder Cancer: A Preliminary Report," Poster presented at The XIIth Congress of The European Association of Urology, Paris, Sep. 1-4, 1996.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US6958075||Sep 18, 2001||Oct 25, 2005||Celsion Corporation||Device and method for treatment of tissue adjacent a bodily conduit by thermocompression|
|US7753907||Jul 13, 2010||Boston Scientific Scimed, Inc.||Medical device systems and methods|
|US7811313||Oct 12, 2010||Boston Scientific Corporation||Device for treatment of tissue adjacent a bodily conduit by thermocompression|
|US7837720||Nov 23, 2010||Boston Scientific Corporation||Apparatus for treatment of tissue adjacent a bodily conduit with a gene or drug-coated compression balloon|
|US8221413||Jul 17, 2012||Boston Scientific Corporation||Device and method for treatment of tissue adjacent a bodily conduit by thermocompression|
|US8221414||Jul 17, 2012||Boston Scientific Corporation||Catheter|
|US8224455||Jul 17, 2012||Boston Scientific Corporation||Drug delivery|
|US8374702||Feb 12, 2013||Medifocus, Inc.||Drug delivery|
|US20030229384 *||May 13, 2003||Dec 11, 2003||Celsion Corporation||Method and apparatus for treatment of tissue adjacent a bodily conduit with a compression balloon|
|US20050070888 *||Oct 29, 2004||Mar 31, 2005||Boston Scientific Corporation||Medical device systems and methods|
|US20070112342 *||Jan 8, 2007||May 17, 2007||Rita Medical Systems, Inc.||Tissue ablation apparatus and method|
|US20100298913 *||Aug 3, 2010||Nov 25, 2010||Boston Scientific Corporation||Device and method for treatment of tissue adjacent a bodily conduit by thermocompression|
|US20110028886 *||Feb 3, 2011||Boston Scientific Corporation||Catheter|
|US20110034976 *||Feb 10, 2011||John Mon||Drug delivery|
|U.S. Classification||606/27, 607/102, 606/42, 607/105|
|International Classification||A61N5/02, A61F7/12, A61N5/04, A61B18/18|
|Cooperative Classification||A61N5/045, A61F7/123, A61B18/18, A61N5/04|
|European Classification||A61F7/12B, A61B18/18, A61N5/04, A61N5/04B|
|Dec 30, 2002||FPAY||Fee payment|
Year of fee payment: 8
|Jun 20, 2003||AS||Assignment|
Owner name: MEDICAL ENTERPRISES LIMITED, BARBADOS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AIDA ENGINEERING LIMITED;REEL/FRAME:014186/0488
Effective date: 20020626
|Dec 18, 2006||FPAY||Fee payment|
Year of fee payment: 12
|Dec 9, 2008||CC||Certificate of correction|